Company Overview

Development Stage

About the Company

[Summary] Leading enterprise in the field of central nervous system drugs in Chi

Jiangsu Enhua Pharmaceutical Co., Ltd. was founded in 1978 and listed on the Shenzhen Stock Exchange in 2008 with stock code 002262. It is a pharmaceutical enterprise integrating scientific research, industry, and trade, and is a designated manufacturer of national psychotropic and narcotic drugs, a national high-tech enterprise, one of China's top 100 pharmaceutical enterprises, a national technology innovation demonstration enterprise, a national intellectual property demonstration unit, a star unit of pharmaceutical quality management enterprises in the national "20 Years 20 Stars" program, a vice president unit of the China Narcotic Drugs Association, a vice president unit of Jiangsu Pharmaceutical Industry Association, one of the first batch of innovative enterprises in Jiangsu Province, and a winner of the Jiangsu Province Governor Quality Award.

The company mainly produces and operates drugs for the central nervous system, strategically positioned in the central nervous system drug market, mainly engaged in the development, production, and sales of central nervous system drugs. It is an enterprise focusing on the subdivided market of central nervous system drugs, with main categories including anesthetics, psychotropic drugs, and neurological drugs. Through years of unremitting efforts in product R&D, production, and service, the company has established a complete product series and marketing network for central nervous system drugs, striving to become an important domestic manufacturer and distributor of central nervous system drugs.

The company has three large modern pharmaceutical production bases for APIs (Active Pharmaceutical Ingredients) and formulations, covering a total area of more than 900 mu. It has workshops certified by the state for APIs, solid preparations, aqueous injections, and lyophilized powder injections, as well as more than ten automated production lines for tablets, capsules, aqueous injections, and powder injections. Currently, it has a production capacity of 46 APIs at 600 tons per year; more than 110 western medicine preparations, with an annual production scale of 6 billion tablets (capsules) of solid preparations and 200 million injections per year.

According to the enterprise development strategy, the company strives to focus on energy conservation, emission reduction, environmental protection, and green development. It has passed the Energy Management System Certification (ISO50001) and the international environmental certification (ISO14000), vigorously develops API export business, conducts international certifications such as EU certification, and strives to gain a place in the international market.

The company attaches great importance to technological innovation, new product development, and strengthening the integration of industry, academia, and research. The group's technology center is a nationally recognized enterprise technology center and a provincial-level engineering technology research center. It has established an enterprise academician workstation, a national postdoctoral research workstation, a postdoctoral innovation center, and a Jiangsu Province key laboratory for central nervous system drug research, undertaking a number of key national scientific research projects.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Enhua Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 深交所

Enhua Pharmaceutical How Fast Is Hiring Growing? (313 open positions)

Manage
Note: How fast is hiring at Jiangsu Enhua Pharmaceutical Co., Ltd. growing? Enhua Pharmaceutical2025: 905 openings (up 3%), 2024: 879 openings (up 72%), 2023: 511 openings (up 40%), 2022: 365 openings (down 33%), 2021: 547 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Enhua Pharmaceutical Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Jiangsu Enhua Pharmaceutical Co., Ltd. growing? Enhua PharmaceuticalMaster's recruitment over the years: 2025: 49 openings (flat), 2024: 49 openings (down 18%), 2023: 60 openings (up 43%), 2022: 42 openings (down 7%), 2021: 45 openings.

Enhua Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
-46%
Growth Rate
2026 vs 2025
  • 2025: Up 18%
  • 2024: Down 69%
  • 2023: Up 260%
  • 2022: Up 67%
Enhua Pharmaceutical Doctoral Hiring by Year: 2026 — 6 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Jiangsu Enhua Pharmaceutical Co., Ltd. growing? Enhua PharmaceuticalDoctorate recruitment over the years: 2026: 7 openings (down 46%), 2025: 13 openings (up 18%), 2024: 11 openings (down 69%), 2023: 36 openings (up 260%), 2022: 10 openings (up 67%), 2021: 6 openings.

Enhua Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Jiangsu Enhua Pharmaceutical Co., Ltd.? Based on an analysis of Enhua Pharmaceutical's job postings over the past year, "医疗卫生/美容保健类" demand: 23.4%, "计算机/网络/技术类": 15.9%, "生物/制药/化工/环保类": 8.2%, "其他(研发和技术类)": 6.7%, "科研类": 3.6%, "机械/仪器仪表类": 0.9%. For reference only.

Enhua Pharmaceutical — What Are the Salaries Like? (1034 records)

Manage
Enhua Pharmaceutical Salary Overview
salary range: 4.5K - 50K, 67% of roles pay ¥10-20K
Note: salary statistics are based on 1034 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Jiangsu Enhua Pharmaceutical Co., Ltd.?Enhua Pharmaceutical67% of positions earn 10-20K, Fresh graduate salary: ¥8.7K。Xuzhou salary ranking top 20,销售类 average salary ¥14.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Enhua Pharmaceutical

(More)
Are salaries high at Jiangsu Enhua Pharmaceutical Co., Ltd.? We provide: 销售,医药代表,信息,临床,分析,研究员,地区经理,ka,ra,产品经理,医学经理,零售,前端,实习生,qa,检测,项目经理,制剂研究,安全,操作工. Click to view detailed salary analysis by job.

Enhua Pharmaceutical — Fortune 500? (More)

Enhua Pharmaceutical Related Industry Tags

Job Category

  • 销售类
    70.1% of total 70.1%
  • 医疗卫生/美容保健类
    23.4% of total 23.4%
  • 计算机/网络/技术类
    15.6% of total 15.6%
  • 生物/制药/化工/环保类
    9.1% of total 9.1%

Education

  • 大专
    57% of total 57%
  • 本科
    32.5% of total 32.5%
  • 硕士
    9.1% of total 9.1%
  • 博士
    0.9% of total 0.9%

Experience

  • 1-3年
    55.9% of total 55.9%
  • 不限
    24.6% of total 24.6%
  • 3-5年
    14.9% of total 14.9%
  • 5-10年
    3.7% of total 3.7%
View Detailed Analysis

What does Jiangsu Enhua Pharmaceutical Co., Ltd. require? Who is Enhua Pharmaceutical hiring? Enhua Pharmaceutical recruitment: 销售类占比最多占70.1%,其次是医疗卫生/美容保健类占23.4%. What education can get in at Enhua Pharmaceutical? 大专占比最多占57%,其次是本科占32.5%. High education required at Enhua Pharmaceutical? 硕士占9.1%,博士占0.9%. Work experience required at Enhua Pharmaceutical? 1-3年占比最多占55.9%,其次是不限占24.6%. Where are the job locations at Enhua Pharmaceutical? 徐州占比最多占12.6%,其次是北京占4.6%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 101,578.6583万(元)
Legal Representative: 孙彭生
Date Established:
Credit Code: 913203001363846728
Registered Address: 徐州经济技术开发区杨山路18号

Partners & Suppliers

2022年,海思科与恩华药业签署合作协议,授予恩华药业HSK16149胶囊在中国大陆的独家商业化权益,获取首付款及销售分成。 Source
供应商 新药对外许可
恩华药业在西南地区的重要经销伙伴 Source
合作客户 药品流通
恩华药业在浙江省的重要医药流通合作伙伴 Source
合作客户 药品流通
恩华药业在华南地区的主要分销合作商 Source
合作客户 药品流通
恩华药业在江苏省及周边的重要区域经销商 Source
合作客户 药品流通

People who follow Enhua Pharmaceutical also follow

Enhua Pharmaceutical Competitors (Similar Companies)

药物研发 生物制品 新药研发 生物化学
“Research, development, and production of anti-tumor and surgical medic”
变压器 箱式变电站 预装式变电站 电力变压器
电芯 充电电池 电池电芯 生产
“Undertake great responsibilities, follow the great path, and achieve g”
制药/药业 抗肿瘤药 肿瘤药物 医药
“A renowned enterprise in China's liver disease and anti-tumor fields”
医院 康复 康复治疗 康复管理
“Seek and strive, protect and heal all beings”
“Products for the diagnosis and treatment of allergic diseases”
钢结构工程 复合板 建筑施工 工程施工
“Top 10 of China Light Industry Plastic Industry”
光电 摄像头模组 安全监控 手机摄像头模组
新能源 电池 动力电池 充电电池
“中国塑机控制系统领域的领航者”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates